logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Manufacturers
    3. Collegium Pharmaceutical, Inc.

    Collegium Pharmaceutical, Inc. drugs

    FiltersReset Filters
    3 results

    • nucynta

      (tapentadol hydrochloride)
      Collegium Pharmaceutical, Inc.
      Usage: NUCYNTA ER (tapentadol) is indicated for managing severe, persistent pain in adults requiring long-term opioid treatment when alternatives are inadequate, including neuropathic pain associated with diabetic peripheral neuropathy. It is not suitable for as-needed pain management due to addiction and misuse risks.

    • nucynta

      (tapentadol hydrochloride)
      Collegium Pharmaceutical, Inc.
      Usage: NUCYNTA (tapentadol) tablets are indicated for managing acute pain in adults and pediatric patients aged 6 years or older, weighing at least 40 kg, when alternative treatments are inadequate. Use is limited due to risks of addiction and should be for severe pain requiring opioid analgesics.

    • xtampza

      (OXYCODONE)
      Collegium Pharmaceutical, Inc.
      Usage: XTAMPZA ER is indicated for managing severe and persistent pain requiring long-term opioid treatment when alternative options are inadequate. It is not intended for as-needed (prn) use and should be prescribed cautiously due to risks of addiction, abuse, and overdose associated with opioids.